/Companies

Alleviant Medical Inc

Austin, US · Founded 2017 · Delaware corporation · 58 employees on LinkedIn · 10 known investors

Find your way into Alleviant Medical Inc

Sign up to see every warm intro you have to Alleviant Medical Inc

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Alleviant Medical Inc team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Alleviant Medical develops an investigational minimally invasive medical device using interatrial shunt therapy to treat heart failure patients, currently in FDA-approved clinical trials (ALLAY-HF and ALLAY-HFrEF).

Founders & leadership

Alleviant Medical Inc was founded in 2017 by Adam Berman.

AB
Adam BermanFounder · President & CEOAdam Berman is an executive officer and director at Alleviant Medical Inc, a medtech company developing minimally invasive interventional therapies. He has experience as a CEO, board member, and advisor with focus on cardiovascular and structural heart disease applications.
JK
Jacob KriegelNamed on SEC filing
AP
Avni PatelNamed on SEC filing
CA
Christopher Alex ArevalosNamed on SEC filing
AG
Albertien GreijdanusNamed on SEC filing

Board

GPGeoff Pardo
Geoff PardoBoard directorGeneral Partner at Gilde Healthcare
BRBrian R Smith
Brian R SmithBoard directorManaging Director at S3 Ventures
MBMaria Berkman
Maria BerkmanBoard directorPartner at Vensana Capital
KNKirk Nielsen
Kirk NielsenBoard directorCo-Founder and Managing Partner at Vensana Capital
CK
Christopher KasterBoard directorGeneral Partner at Cadence Healthcare Ventures
JSJay Schmelter
Jay SchmelterBoard directorCo-founder of RiverVest Venture Partners, funding and founding life science companies
IMIan Meredith
Ian MeredithIndependent Board MemberDirector at Breakthrough Victoria

Investors · 10

Also in the syndicate · 1

Longview Ventures

Reported raises · per SEC filings

Form D private placements

$148.8M disclosed across 4 rounds · 2017–2024

▶$90.8MraisedJan 2025 · 12 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Geoff PardoDirector
  • Ian MeredithDirector
  • Brian R SmithDirector
  • Maria BerkmanDirector
  • Adam BermanExecutive Officer, Director
  • Kirk NielsenDirector
  • Christopher KasterDirector
  • Jay SchmelterDirector
Offering amount
$91.4M
Amount sold
$90.8M
First sale
Dec 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$43.9MraisedFeb 2023 · 35 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Brian R SmithDirector
  • Gowda AshokDirector
  • Kirk NielsonDirector
  • Christopher KasterDirector
  • Maria BerkmanDirector
  • Jay SchmelterDirector
  • Adam BermanExecutive Officer, Director
Offering amount
$88.3M
Amount sold
$43.9M
First sale
Jan 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$13MraisedNov 2020 · 18 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Mary ByronDirector
  • Ashok GowdaDirector
  • Christopher KasterDirector
  • Kirk NielsenDirector
  • Adam BermanExecutive Officer, Director
  • Jacob KriegelDirector
  • Maria BerkmanDirector
Offering amount
$20M
Amount sold
$13M
First sale
May 2020
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.1MraisedMar 2018 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jacob KriegelExecutive Officer, Director
  • Avni PatelExecutive Officer, Director
  • Christopher Alex ArevalosExecutive Officer, Director
  • Albertien GreijdanusExecutive Officer, Director
Offering amount
$1.5M
Amount sold
$1.1M
First sale
Dec 2017
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

Companies working in the same space as Alleviant Medical Inc.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2022$1.9M
National Institutes of Health (NIH)National Institutes of HealthPhase I2018$313.6K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Alleviant Medical Inc do?
Alleviant Medical develops an investigational minimally invasive medical device using interatrial shunt therapy to treat heart failure patients, currently in FDA-approved clinical trials (ALLAY-HF and ALLAY-HFrEF).
Who founded Alleviant Medical Inc?
Alleviant Medical Inc was founded by Adam Berman in 2017.
Who are Alleviant Medical Inc's investors?
Alleviant Medical Inc's investors include Broadview Ventures, RiverVest Venture Partners, TMC Venture Fund, Cadence Healthcare Ventures, Gilde Healthcare, Gilmartin Capital LLC, Omega Funds, S3 Ventures and 1 more.
How much funding has Alleviant Medical Inc raised?
Alleviant Medical Inc has disclosed $148.8M raised across 4 rounds.
Where is Alleviant Medical Inc headquartered?
Alleviant Medical Inc is headquartered in Austin, US.